CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...

A column published in The New York Times claimed the public was "badly misled" about the origins of COVID, even after its own ...

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...

A screen of human-infecting viruses identified extensive examples of viral proteins that resembled human sequences, which ...

While other viruses can produce similar effects, this is the first time this specific behavior has been spotted. Researchers ...

Richard Adeleke, a doctoral researcher at Cornell University, New York, USA, and his research group have developed a groundbreaking vaccine that could protect people from both COVID-19 and the flu in ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

The following is a summary of “A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 ...